2021-2023年WHO东地中海区域COVID-19疫苗部署:如何转向生命全程方法
本文回顾了WHO东地中海区域22个国家2021-2023年COVID-19疫苗部署、覆盖率、接种意愿及整合进展。截至2023年12月31日,基础免疫覆盖率为51%,首剂加强针为19%;高收入国家覆盖率高于其他收入组。接种意愿从2021年6-7月的20%上升至2022年6-7月的77%。22国中20国已将COVID-19疫苗接种完全或部分整合入扩大免疫规划(EPI)和初级卫生保健(PHC)。
要点
- 截至2023年12月31日,东地中海区域基础免疫覆盖率为51%,首剂加强针为19%。
- 高收入国家基础免疫和首剂加强针覆盖率分别为77%和44%,高于其他收入组。
- 接种意愿从2021年6-7月的20%上升至2022年6-7月的77%。
核心结论
- 由于人群对Omicron变异株关注度降低,覆盖高风险群体的挑战持续存在;各国应利用COVID-19疫苗接种积累的信任、势头和经验,为最高风险群体接种疫苗,并将COVID-19疫苗交付从有时限的项目式方法转向可持续的长期方法,整合入常规EPI和PHC。
研究设计与样本
- 本文为对WHO东地中海区域2021-2023年COVID-19疫苗部署、覆盖率、接种意愿和整合进展的回顾性综述,覆盖该区域22个国家。
主要发现
- 截至2023年12月31日,东地中海区域基础免疫覆盖率为51%,首剂加强针覆盖率为19%。
- 高收入国家基础免疫和首剂加强针覆盖率分别为77%和44%,高于中高收入国家的49%和20%、AMC非Gavi eligible国家的47%和15%以及AMC Gavi eligible国家的49%和16%。
- 13个国家报告了医护人员覆盖率(基础免疫76%,首剂加强针43%),15个国家报告了老年人覆盖率(基础免疫69%,首剂加强针38%)。
- 2021-2022年三轮区域知识、态度和实践(KAP)调查显示,COVID-19疫苗接受度从2021年6-7月的20%上升至2021年10-11月的62%,2022年6-7月为77%;未接种但有意接种者从60%降至23%和11%;未接种且无接种意愿者从15%降至10%和11%。
- 区域内22个国家中20个已将COVID-19疫苗接种完全或部分整合入EPI和PHC。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In 2020-2021, all countries of the WHO Eastern Mediterranean Region [EMR] introduced COVID-19 vaccine with inequalities in coverage across countries. As for 2023, we reviewed subsequent progress in deployment, coverage, acceptance, and integration. As of 31 December 2023, coverage in EMR reached 51% for primary series and 19 % for the first booster, higher in high income countries (77 % and 44 %, respectively) than in upper middle-income countries (49 % and 20 %), Advance Market Commitment [AMC] non-Gavi eligible countries (47 % and 15 %) and AMC Gavi eligible countries (49 % and 16 %). Thirteen countries measured coverage among healthcare workers (76 % and 43 %, respectively) and 15 among elderly (69 % and 38 %, respectively). Three rounds of the regional Knowledge, Attitudes, and Practices [KAP] survey on COVID-19 vaccine acceptance in 2021-2022 indicated that acceptance increased from 20 % in June-July 2021 to 62 % in October-November 2021, and 77 % in June-July 2022. Those unvaccinated but intending to be vaccinated decreased from 60 % to 23 % and 11 %, respectively. Unvaccinated without intention to be vaccinated decreased from 15 % to 10 % and 11 %, respectively. Twenty out of 22 countries in the region had completely or partially integrated COVID-19 vaccination into the Expanded Programme on Immunization [EPI] and Primary Health Care [PHC]. Overall, challenges to reach high-risk groups persisted as the population was less concerned about Omicron variant of the SARS-CoV-2 virus. Countries should build on the trust, momentum, and lesson-learned generated from COVID-19 vaccination to get the highest risk groups vaccinated and switch from a time bound and project type approach to a sustainable and long-term approach for COVID-19 vaccine delivery that would be integrated into the routine EPI and PHC.
引用
- Bak J, Hasan Q, Kissa J, et al. Deployment of COVID-19 vaccine in the WHO Eastern Mediterranean Region 2021-23: How do we switch to a life course approach? Vaccine. 2024. PMID: 38796325. doi:10.1016/j.vaccine.2024.05.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。